Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies

Author(s):  Maham Nicole Y

Issue:  Nov/Dec 2022 - Volume 26, Number 6
View All Articles in Issue

Page(s):  474-479

Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 1
Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 2
Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 3
Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 4
Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 5
Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 6

Download in electronic PDF format for $65

Abstract:  Patients’ responses to medical treatment vary greatly; while many may benefit from pharmacological therapy, others may suffer from harmful drug reactions or show no response at all. To provide an effective individualized care, one must understand the elements that lead to varying patient outcomes and how these factors may interplay in an individual’s treatment outcome. Pharmacogenomics is the future of pharmacy, and there is a growing demand for this service. Compounding pharmacies are already at the forefront of meeting patients’ unique drug requirements. This gives them the opportunity to provide their patients with more valuable services than only selling drugs dictated by the formula! This article discusses pharmacogenomics as a competitive strategy for compounding pharmacies.

Related Keywords: Nicole Y. Maham, PharmD Candidate, MS(s) (Biomedical Science and IT Management), BS (Industrial Management), treatment outcomes, pharmacogenomics, drug response, personalized medicine, pharmacokinetics, pharmacodynamics, genetic polymorphism, genome-wide association studies, single-nucleotide polymorphisms, copy number variations, Clinical Pharmacogenomics Implementation Consortium, CPIC, gene-drug pairings, metabolizer phenotypes, pharmacogenomics implementation models, pharmacogenomic counseling, genetic counselors

Related Categories: BUSINESS, MARKETING, TECHNOLOGY, PATIENT ASSESSMENT, PROFESSIONAL ISSUES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies
Maham Nicole Y
Nov/Dec 2022
Pg. 474-479

Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Soni Abhishek
, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Mar/Apr 2018
Pg. 108-121

Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2
Allen Loyd V
Jul/Aug 2015
Pg. 280-287

Sensitization Therapy for Warts
Kuntz Rachael
Jul/Aug 2003
Pg. 266-270

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Five Compounds for Treating Diabetes-Related Conditions
Meece Jerry
May/Jun 2003
Pg. 170-174

Pharmacogenomics: The End of Trial-and-Error Medicine?
Vail Jane
Jan/Feb 2007
Pg. 59-65

Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2015
Pg. 295-300

Pharmacogenomics: Precision Pharmacy in 503A Compounding
Drummond Joseph
, Bennet Daron, Allen Loyd V Jr
Mar/Apr 2018
Pg. 95-107

Pitch Ointment: Applications in Scar and Wound Management
Kloesel Lawson
, Carvalho Maria, Banov Fabiana
May/Jun 2018
Pg. 182-188

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions